OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prostaglandin E2 EP receptors in cardiovascular disease: An update
Timothy D. Bryson, Pamela Harding
Biochemical Pharmacology (2021) Vol. 195, pp. 114858-114858
Closed Access | Times Cited: 22

Showing 22 citing articles:

EP1 activation inhibits doxorubicin-cardiomyocyte ferroptosis via Nrf2
Bei Wang, Yuxuan Jin, Jiao Liu, et al.
Redox Biology (2023) Vol. 65, pp. 102825-102825
Open Access | Times Cited: 42

The Link between Prostanoids and Cardiovascular Diseases
Livia Beccacece, Paolo Abondio, Carla Bini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4193-4193
Open Access | Times Cited: 28

Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease
Frank Geurts, Layal Chaker, Anna C. van der Burgh, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 5

Skeletal interoception and prospective application in biomaterials for bone regeneration
Long Bai, Jilong Li, Guangfeng Li, et al.
Bone Research (2025) Vol. 13, Iss. 1
Open Access

The Interaction of Human Papillomavirus Infection and Prostaglandin E2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics
Janice García‐Quiroz, Bismarck Vázquez-Almazán, Rocío García‐Becerra, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2528-2528
Open Access | Times Cited: 18

Research progress on the protective effect of hormones and hormone drugs in myocardial ischemia-reperfusion injury
Zhongyi Wang, G H Zhang, Shan Hu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116764-116764
Open Access | Times Cited: 2

The Effect of Targeted Temperature Management on the Metabolome Following Out-of-Hospital Cardiac Arrest
Rasmus Paulin Beske, Laust Emil Roelsgaard Obling, John Bro-Jeppesen, et al.
Therapeutic Hypothermia and Temperature Management (2023) Vol. 13, Iss. 4, pp. 208-215
Closed Access | Times Cited: 6

PGE2 protects against heart failure through inhibiting TGF-β1 synthesis in cardiomyocytes and crosstalk between TGF-β1 and GRK2
Jing Fu, Li Li, Long Chen, et al.
Journal of Molecular and Cellular Cardiology (2022) Vol. 172, pp. 63-77
Closed Access | Times Cited: 9

Deleterious effects of cardiomyocyte-specific prostaglandin E2 EP3 receptor overexpression on cardiac function after myocardial infarction
DruAnne L. Maxwell, Timothy D. Bryson, David Taube, et al.
Life Sciences (2022) Vol. 313, pp. 121277-121277
Open Access | Times Cited: 8

RNA sequencing provides novel insights into the pathogenesis of naturally occurring myxomatous mitral valve disease stage B1 in beagle dogs
Tae-Seok Kim, Chae-Yeon Hong, Seong-Ju Oh, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0300813-e0300813
Open Access | Times Cited: 1

Exploring the Anti-inflammatory Potential of Novel Chrysin Derivatives through Cyclooxygenase-2 Inhibition
Yuna Lee, Eun Ji Gu, Ha-Yeon Song, et al.
ACS Omega (2024) Vol. 9, Iss. 51, pp. 50491-50503
Closed Access | Times Cited: 1

A metabolome-wide case-control study of african american breast cancer patients
Jiajun Luo, Muhammad G. Kibriya, Hui Chen, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3

Identification through machine learning of potential immune- related gene biomarkers associated with immune cell infiltration in myocardial infarction
Hao Dong, Shi-Bai Yan, Guosheng Li, et al.
BMC Cardiovascular Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3

Prostaglandin E2 and myocarditis; friend or foe?
Timothy D. Bryson, Pamela Harding
Biochemical Pharmacology (2023) Vol. 217, pp. 115813-115813
Closed Access | Times Cited: 2

Prostaglandin E2 affects mitochondrial function in adult mouse cardiomyocytes and hearts
Timothy D. Bryson, Matthew Zurek, Carlin Moore, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2024) Vol. 201, pp. 102614-102614
Open Access

Targeted Gene Deletion or Antagonism of the Prostaglandin E2 EP3 Receptor Protects Against Cardiac Injury Postmyocardial Infarction
Timothy D. Bryson, Shaheen Yawar Bhat, Carlin Moore, et al.
Circulation Heart Failure (2024) Vol. 17, Iss. 4
Open Access

Genetic Modifications to Alter Blood Pressure Level
Hiroki Ohara, Toru Nabika
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1855-1855
Open Access | Times Cited: 2

The combined action of glycoinositolphospholipid from Trypanosoma cruzi and macrophage migration inhibitory factor increases proinflammatory mediator production by cardiomyocytes and vascular endothelial cells
Cristina S. Rigazio, Nilo Mariz-Ponte, Eugenia Pérez Caballero, et al.
Microbial Pathogenesis (2022) Vol. 173, pp. 105881-105881
Closed Access | Times Cited: 2

Introduction to the lipid mediators special issue
Oliver Werz
Biochemical Pharmacology (2022) Vol. 207, pp. 115375-115375
Closed Access | Times Cited: 2

The Deleterious Consequences of a Nonsteroidal Anti-inflammatory Drug in an Eisenmenger Patient
Sarah Grütter, David Haefliger, Grégoire Wuerzner, et al.
CJC Pediatric and Congenital Heart Disease (2023) Vol. 3, Iss. 1, pp. 11-13
Open Access

A moderate dosage of prostaglandin E2-mediated annexin A1 upregulation promotes alkali-burned corneal repair
Hongling Liu, Xue Zhang, Qiang Tan, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108565-108565
Open Access

Page 1

Scroll to top